Ritacco Ida, Al Assy Merriam, Abd El-Rahman Mohamed K, Fahmy Sherif Ashraf, Russo Nino, Shoeib Tamer, Sicilia Emilia
Department of Chemistry and Chemical Technologies, University of Calabria , Arcavacata di Rende 87036, Italy.
Department of Chemistry, The American University in Cairo , New Cairo 11835, Egypt.
Inorg Chem. 2017 May 15;56(10):6013-6026. doi: 10.1021/acs.inorgchem.7b00945. Epub 2017 Apr 28.
For the synthesis and selection of active platinum-based anticancer drugs that perform better than cisplatin and its analogues, six-coordinate octahedral Pt(IV) complexes appear to be promising candidates as, being kinetically more inert and more resistant to ligand substitution than four-coordinate Pt(II) centers, they are able to minimize unwanted side reactions with biomolecules prior to DNA binding. Due to their kinetic inertness, Pt(IV) complexes have also been exploited to bypass inconvenient intravenous administration. The most prominent example is satraplatin (Sat.) which is the first platinum antineoplastic agent reported to have oral activity. The present paper deals with a theoretical DFT investigation of the influence that the acidity of the biological environment can have on the activity of satraplatin and analogous octahedral Pt(IV) complexes having two carboxylates as axial ligands. Moreover, here the outcomes of a joint electrospray ionization mass spectrometry and DFT investigation of the fragmentation pathways of the protonated satraplatin are reported. Calculations show that the simulated acidic environment has an important impact on the satraplatin reactivity causing a significant lowering of the barrier that is necessary to overcome for the hydrolysis of the first acetate ligand to occur. Data from electrospray ionization mass spectrometry, H NMR, and potentiometric experiments strongly suggest that the loss of CHCOOH from the protonated satraplatin ion [Sat. + H] takes place almost immediately upon dissolution of satraplatin in methanol-water, DO, and water solutions, respectively, at room temperature.
为了合成和筛选比顺铂及其类似物性能更优的活性铂基抗癌药物,六配位八面体Pt(IV)配合物似乎是很有前景的候选物。因为与四配位Pt(II)中心相比,它们在动力学上更惰性,对配体取代反应更具抗性,所以能够在与DNA结合之前将与生物分子发生的不必要副反应降至最低。由于其动力学惰性,Pt(IV)配合物还被用于避免不便的静脉给药。最突出的例子是沙铂(Sat.),它是首个被报道具有口服活性的铂类抗肿瘤药物。本文通过密度泛函理论(DFT)研究了生物环境的酸度对沙铂以及具有两个羧酸盐作为轴向配体的类似八面体Pt(IV)配合物活性的影响。此外,本文还报道了电喷雾电离质谱与DFT联合研究质子化沙铂裂解途径的结果。计算表明,模拟的酸性环境对沙铂的反应活性有重要影响,导致第一个乙酸酯配体发生水解所需克服的势垒显著降低。电喷雾电离质谱、核磁共振氢谱(H NMR)和电位滴定实验的数据有力地表明,质子化沙铂离子[Sat. + H]在室温下分别溶解于甲醇 - 水、重水(DO)和水溶液中后,几乎立即会失去CHCOOH。